John J. Alam - Sep 15, 2023 Form 4 Insider Report for CervoMed Inc. (DFFN)

Signature
/s/ William R. Elder, attorney-in-fact for the Reporting Person
Stock symbol
DFFN
Transactions as of
Sep 15, 2023
Transactions value $
$0
Form type
4
Date filed
9/15/2023, 06:54 PM
Previous filing
Aug 23, 2023
Next filing
Nov 9, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DFFN Stock Option (Right to Buy) Award $0 +35.5K $0.00 35.5K Sep 15, 2023 Common Stock 35.5K $5.33 Direct F1
transaction DFFN Stock Option (Right to Buy) Award $0 +6.45K $0.00 6.45K Sep 15, 2023 Common Stock 6.45K $5.33 By Spouse F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing September 30, 2023.
F2 Consists of an option to purchase shares of common stock granted to Sylvie Gregoire, Pharm.D., the Reporting Person's spouse and the Chair of the Board of the Issuer. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.